Department of Cardiothoracic Surgery, Shenzhen Children's Hospital, Shenzhen, China.
Perfusion. 2024 Sep;39(6):1167-1173. doi: 10.1177/02676591231180997. Epub 2023 Jun 8.
Cardiopulmonary bypass (CPB) causes coagulation disorders after surgery. This study aimed to compare the coagulation parameters after congenital cardiac surgery with miniaturised CPB (MCPB) versus conventional CPB (CCPB).
We gathered information about children who underwent cardiac surgery between 1/1/2016 and 12/31/2019. Using propensity score-matched data, we compared the coagulation parameters and postoperative outcomes of the MCPB and CCPB groups.
A total of 496 patients (327 with MCPB, 169 withCCPB) underwent congenital cardiac surgery, and 160 matched pairs in each group were enrolled in the analysis. Compared with CCPB children, MCPB children had a lowermean prothrombin time (14.9 ± 2.0 vs 16.4 ± 4.1; < 0.001)and international normalised ratio (1.3 ± 0.2 vs. 1.4 ± 0.3; < 0.001), but higher thrombin time (23.4 ± 20.4 vs 18.2 ± 4.4; = 0.002). The CCPB group had greaterperioperative changes inprothrombin time, international normalised ratio, fibrinogen, and antithrombin III activity (all < 0.01) but lower perioperative changesin thrombin time ( = 0.001) thanthe MCPB group. Ultra-fasttrack extubation and blood transfusionrates, postoperative blood loss, and intensive care unitlength of stay were considerably decreased in the MCPB group. There were no considerable intergroup differences in the activated partial thromboplastin time or platelet count.
Compared with CCPB, MCPB was associated with lower coagulation changes and better early outcomes, including shorter intensive care unit stay and less postoperative blood loss.
体外循环(CPB)术后会引起凝血功能障碍。本研究旨在比较微创 CPB(MCPB)与常规 CPB(CCPB)用于先天性心脏手术后的凝血参数。
我们收集了 2016 年 1 月 1 日至 2019 年 12 月 31 日期间接受心脏手术的儿童信息。通过倾向评分匹配数据,我们比较了 MCPB 和 CCPB 组的凝血参数和术后结局。
共有 496 例患者(MCPB 组 327 例,CCPB 组 169 例)接受了先天性心脏手术,每组纳入 160 对匹配患者。与 CCPB 患儿相比,MCPB 患儿的平均凝血酶原时间(14.9 ± 2.0 比 16.4 ± 4.1; <0.001)和国际标准化比值(1.3 ± 0.2 比 1.4 ± 0.3; <0.001)较低,但凝血酶时间(23.4 ± 20.4 比 18.2 ± 4.4; = 0.002)较高。CCPB 组凝血酶原时间、国际标准化比值、纤维蛋白原和抗凝血酶 III 活性的围手术期变化较大(均 <0.01),而 MCPB 组凝血酶时间的围手术期变化较小( = 0.001)。MCPB 组的快速康复拔管率和输血率、术后出血量和重症监护病房住院时间明显降低。两组间的活化部分凝血活酶时间或血小板计数无明显差异。
与 CCPB 相比,MCPB 与较低的凝血变化和更好的早期结局相关,包括较短的重症监护病房住院时间和较少的术后出血量。